According to www.techsciresearch.com latest Report- Global remdesivir market is expected to grow at an impressive rate during the forecast period. The global remdesivir market is driven by the increasing prevalence of COVID-19 disease across different parts of the globe. Report URL- https://www.techsciresearch.com/report/remdesivir-market/4714.html

1. MARKET INTELLIGENCE . CONSULTING
www.techsciresearch.com
GLOBAL REMDESIVIR MARKET
FORECAST & OPPORTUNITIES
2015 – 2025

2. 2
Scope of Report
Product of Interest (POI): Remdesivir
Review Period
2015 – 2018
Base Year
2019
Estimated Year
2020
Forecast Period
2021 – 2025
Year Range
REGION
• Asia-Pacific
• Europe
• North America
• South America
• Middle East &
Africa
Global remdesivir market is expected to grow at an impressive rate during the forecast
period. The global remdesivir market is driven by increasing prevalence of COVID-19
disease across different parts of the globe. WHO directed to start clinical trials for
remdesivir along with three other drugs that were found to be useful in the treatment of
COVID-19. The drug has now entered the phase 3 of the clinical trials and it is anticipated
that it will emerge out as a successful cure for coronavirus.
Market Segmentation
DOSAGE
• 10 mM*1 mL
in DMSO
• 5mg
• 10mg
• 50mg
• 100mg
• Hospitals
• Clinics
• Drug
Stores/Pharmacies
• Online
• Others
DISTRIBUTION
CHANNEL
ROUTE OF
ADMINISTRATION
• Oral
• Intravenous
APPLICATION
• Ebola
• SARS-COV
• MERS-COV
• COVID-19
DOSAGE FORM
• Tablets
• Frozen Solution
• Lypholized Solution

3. 3
Table of Contents
S. No. Contents Page No.
1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on Global Remdesivir Market
4. Executive Summary
5. Voice of Customer
6. Global Remdesivir Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Dosage (10 mM*1 mL in DMSO, 5mg, 10mg, 50mg, 100mg)
6.2.2. By Route of Administration (Oral v/s Intravenous)
6.2.3. By Dosage Form (Tablets, Frozen Solution, Lypholized Solution)
6.2.4. By Distribution Channel (Hospitals, Clinics, Drug Stores/Pharmacies, Online, Others)
6.2.5 By Application (Ebola, SARS-COV, MERS-COV, COVID-19)
6.2.6. By Company (2019)
6.2.7. By Region (Asia-Pacific, Europe, North America, South America and Middle East & Africa)
6.3. Product Market Map

4. 4
Table of Contents
S. No. Contents Page No.
7. Asia-Pacific Remdesivir Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Dosage
7.2.2. By Route of Administration
7.2.3. By Dosage Form
7.2.4. By Distribution Channel
7.2.5. By Application
7.2.6. By Country (China, India, Australia, Japan, South Korea)
7.3. Asia-Pacific: Country Analysis
7.3.1. China Remdesivir Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Dosage
7.3.1.2.2. By Route of Administration
7.3.1.2.3. By Dosage Form
7.3.1.2.4. By Distribution Channel
7.3.1.2.5. By Application

5. 5
Table of Contents
S. No. Contents Page No.
7.3.2. India Remdesivir Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Dosage
7.3.2.2.2. By Route of Administration
7.3.2.2.3. By Dosage Form
7.3.2.2.4. By Distribution Channel
7.3.2.2.5. By Application
7.3.3. Australia Remdesivir Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Dosage
7.3.3.2.2. By Route of Administration
7.3.3.2.3. By Dosage Form
7.3.3.2.4. By Distribution Channel
7.3.3.2.5. By Application
7.3.4. Japan Remdesivir Market Outlook

6. 6
Table of Contents
S. No. Contents Page No.
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Dosage
7.3.4.2.2. By Route of Administration
7.3.4.2.3. By Dosage Form
7.3.4.2.4. By Distribution Channel
7.3.4.2.5. By Application
7.3.5. South Korea Remdesivir Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Dosage
7.3.5.2.2. By Route of Administration
7.3.5.2.3. By Dosage Form
7.3.5.2.4. By Distribution Channel
7.3.5.2.5. By Application
8. Europe Remdesivir Market Outlook

7. 7
Table of Contents
S. No. Contents Page No.
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Dosage
8.2.2. By Route of Administration
8.2.3. By Dosage Form
8.2.4. By Distribution Channel
8.2.5. By Application
8.2.6. By Country (France, Germany, United Kingdom, Italy, Spain)
8.3. Europe: Country Analysis
8.3.1. France Remdesivir Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Dosage
8.3.1.2.2. By Route of Administration
8.3.1.2.3. By Dosage Form
8.3.1.2.4. By Distribution Channel
8.3.1.2.5. By Application

8. 8
Table of Contents
Contents Page No.
8.3.2. Germany Remdesivir Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Dosage
8.3.2.2.2. By Route of Administration
8.3.2.2.3. By Dosage Form
8.3.2.2.4. By Distribution Channel
8.3.2.2.5. By Application
8.3.3. United Kingdom Remdesivir Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Dosage
8.3.3.2.2. By Route of Administration
8.3.3.2.3. By Dosage Form
8.3.3.2.4. By Distribution Channel
8.3.3.2.5. By Application

9. 9
Table of Contents
S. No. Contents Page No.
8.3.4. Italy Remdesivir Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Dosage
8.3.4.2.2. By Route of Administration
8.3.4.2.3. By Dosage Form
8.3.4.2.4. By Distribution Channel
8.3.4.2.5. By Application
8.3.5. Spain Remdesivir Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Dosage
8.3.5.2.2. By Route of Administration
8.3.5.2.3. By Dosage Form
8.3.5.2.4. By Distribution Channel
8.3.5.2.5 By Application
9. North America Remdesivir Market Outlook
9.1. Market Size & Forecast

10. 10
Table of Contents
S. No. Contents Page No.
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Dosage
9.2.2. By Route of Administration
9.2.3. By Dosage Form
9.2.4. By Distribution Channel
9.2.5. By Application
9.2.6. By Country (United States, Canada, Mexico)
9.3. North America: Country Analysis
9.3.1. United States Remdesivir Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Dosage
9.3.1.2.2. By Route of Administration
9.3.1.2.3. By Dosage Form
9.3.1.2.4. By Distribution Channel
9.3.1.2.5. By Application
9.3.2. Canada Remdesivir Market Outlook

11. 11
Table of Contents
S. No. Contents Page No.
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Dosage
9.3.2.2.2. By Route of Administration
9.3.2.2.3. By Dosage Form
9.3.2.2.4. By Distribution Channel
9.3.2.2.5. By Application
9.3.3. Mexico Remdesivir Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Dosage
9.3.3.2.2. By Route of Administration
9.3.3.2.3. By Dosage Form
9.3.3.2.4. By Distribution Channel
9.3.3.2.5. By Application
10. South America Remdesivir Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast

12. 12
Table of Contents
S. No. Contents Page No.
10.2.1. By Dosage
10.2.2. By Route of Administration
10.2.3. By Dosage Form
10.2.4 By Distribution Channel
10.2.5. By Application
10.2.6. By Country (Brazil, Argentina, Colombia)
10.3. South America: Country Analysis
10.3.1. Brazil Remdesivir Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1 By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Dosage
10.3.1.2.2. By Route of Administration
10.3.1.2.3. By Dosage Form
10.3.1.2.4. By Distribution Channel
10.3.1.2.5. By Application
10.3.2. Argentina Remdesivir Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1 By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Dosage
10.3.2.2.2. By Route of Administration
10.3.2.2.3. By Dosage Form

13. 13
Table of Contents
S. No. Contents Page No.
10.3.2.2.4. By Distribution Channel
10.3.2.2.5. By Application
10.3.3. Colombia Remdesivir Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1 By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Dosage
10.3.3.2.2. By Route of Administration
10.3.3.2.3. By Dosage Form
10.3.3.2.4. By Distribution Channel
10.3.3.2.5. By Application
11. Middle East & Africa Remdesivir Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Dosage
11.2.2. By Route of Administration
11.2.3. By Dosage Form
11.2.4. By Distribution Channel
11.2.5. By Application
11.2.6. By Country (South Africa, Saudi Arabia, UAE, Kuwait)
11.3. Middle East & Africa : Country Analysis

14. 14
Table of Contents
S. No. Contents Page No.
11.3.1. South Africa Remdesivir Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Dosage
11.3.1.2.2. By Route of Administration
11.3.1.2.3. By Dosage Form
11.3.1.2.4. By Distribution Channel
11.3.1.2.5. By Application
11.3.2. Saudi Arabia Remdesivir Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Dosage
11.3.2.2.2. By Route of Administration
11.3.2.2.3. By Dosage Form
11.3.2.2.4. By Distribution Channel
11.3.2.2.5. By Application
11.3.3. UAE Remdesivir Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Dosage

15. 15
Table of Contents
S. No. Contents Page No.
11.3.3.2.2. By Route of Administration
11.3.3.2.3. By Dosage Form
11.3.3.2.4. By Distribution Channel
11.3.3.2.5. By Application
11.3.4. Kuwait Remdesivir Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Dosage
11.3.4.2.2. By Route of Administration
11.3.4.2.3. By Dosage Form
11.3.4.2.4. By Distribution Channel
11.3.4.2.5. By Application
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Pricing Analysis
15. Patent Analysis
16. Competitive Landscape
17. Strategic Recommendations
18. About Us & Disclaimer

16. RESEARCHMETHODOLOGY

17. 17
Research Methodology
 Identifying Key Opinion
Leaders
 Questionnaire Design
 In-depth Interviews
Data
Collection
Developing List
of Respondents
Formulating
Questionnaire
Market
Profiling
Data
Validation
Data
Analysis
In-depth secondary
research was conducted to
determine top players in
the global remdesivir
market, overall market size
and segmental market size.
In order to conduct
industry experts’
interviews, TechSci
formulated a detailed
discussion guide.
List of industry
players and industry
specialists was
developed.
TechSci conducted
interviews with
industry experts and
industry players for
data collection and
verification.
Data obtained as a
result of primary
and secondary
research was
validated through
rigorous
triangulation.
The data was scrutinized
using MS-Excel, statistical
tools and internal
proprietary database to
obtain qualitative and
quantitative insights about
the global remdesivir
market.
Data
Collection
Data Filter
& Analysis
Research &
Intelligence
Actionable
Insights
Business
Solution
Primary Research Desk Research Company Analysis
 Recent Developments
 Market Changing
Aspects/Dynamics
 Government Policies
 Conclusion
 Market Participants
 Key Strengths
 LinkedIn
 TechSci Internal
Database
 Factiva
 Hoovers
Paid Sources
 Company Websites
 Company Annual
Reports
 White Paper Study
 Financial Reports
 Investor
Presentations
 Regulatory Body
 Associations, etc.
Secondary
Research
Primary Research

18. 18
Research Methodology
Baseline Methodology
Our dedicated team of industry experts has monitored and analyzed various aspects of the global remdesivir market. The team has
market, while considering the the major influencing factors such as the increasing prevalence of COVID-19 disease across different
forecasting, which would enable our clients to take better decisions while planning their strategy to achieve sustainability in the global
Methodology Followed for Calculation of Market Size:
• Market Size by Value: Market size, in terms of value, for the year 2019 was calculated based on information collected through
exhaustive secondary research and primary surveys, with various key opinion leaders/stakeholders, such as remdesivir companies,
users, industry experts, and other industry participants.
• The team interviewed more than 15 – 20 remdesivir companies, 100 – 120 end-users, and 15 – 20 industry experts and other value
market to obtain the overall market size from 2015 to 2019, which was validated by the Delphi technique. Taking standard deviation
out, to arrive at the market size data during 2015-2019.

19. 19
Research Methodology
• Respondents were asked about the current and future market growth rates, market shares by dosage, by route of administration, by dosage form, by distribution channel, by
application, by company and by region. Removing the outlier responses, the geometric mean of growth estimates and provider wise revenue shares generated across various
segments were considered, to arrive at the final revenue shares. Revenue shares generated across various segments were further triangulated from other stakeholders.
Methodology Followed for Calculation of Market Shares:
Market share by dosage, by route of administration, by dosage form, by distribution channel, by application, by company and by region were calculated based on the responses received
through primary surveys with industry experts, in which the respondents were asked about the market shares or revenue generated from various segments of remdesivir markets. The
final shares were calculated by taking the geometric mean of the responses gathered from key opinion leaders after eliminating the outliers.
Methodology Followed for Forecasting:
• TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey results in SPSS/Tableau Software.
• Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast global remdesivir market, TechSci Research used
various forecast techniques such as:
 Moving Average
 Time Series Analysis
 Regression Analysis
 Econometric and Judgmental Analysis

20. 20
Research Methodology
TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research also used the impact analysis during
short, medium and long term period to estimate the demand and to reach accurate market numbers. It should be noted that the figures compiled are only for the organized market
including market share data. The currency used in the report is the United States Dollar (USD), with the market size indicated in USD million.
Partial List of Companies Interviewed Key Secondary Sources
• Gilead Sciences, Inc.
• Bright Gene
• Hainan Haiyao
• Kelun Pharma
• Hunan Warrant Pharmaceutical
• Cipla
• Pfizer
• Merck
• Cayman Chemical
• Dr Reddy's Laboratories
 World Bank
 TechSci Research Proprietary Database & Knowledge Repository
 Company Annual Reports
 Industry Magazines
 Industry Reports
 News Dailies
 Credible Paid Databases

21. 21
INDUSTRY BRIEF
According to TechSci Research report, “Global Remdesivir Market By Dosage (10 mM*1 mL in DMSO, 5mg, 10mg, 50mg, 100mg), By Route of Administration (Oral v/s Intravenous), By Dosage
Form (Tablets, Frozen Solution, Lypholized Solution), By Distribution Channel (Hospitals, Clinics, Drug Stores/Pharmacies, Online, Others), By Application (Ebola, SARS-COV, MERS-COV, COVID-
19), By Region, Forecast & Opportunities, 2025”, the global remdesivir market is expected to grow at an impressive rate during the forecast period on account of the growing use of the drug in
treatment of various diseases such as COVID-19, Ebola, SARS-COV, MERS-COV, among others. The use of the drug for treatment of COVID-19, which once failed in treating Ebola, has now
received an orphan drug status and clinical trials have begun for finding out its use in treating novel coronavirus disease. At present, Gilead Sciences, Inc. is running phase 3 clinical trials in Asia-
Pacific, Europe and United States. The trial is divided into two parts, the first comprising the use of drug for treating severe cases and the other for treating patients with moderate symptoms. The
study will also determine if they can reduce the treatment duration from 10 to 5 days. Though nothing has been proven yet, but the drug is being used on compassionate use basis for the treatment
of COVID-19. However, the drug is still in clinical trials and has not been approved by the FDA. This might hamper the market growth. Also, the drug has once failed in treating Ebola, therefore there
are various doubts and myths in the market regarding its use. Additionally, nothing is known about the cost of this drug and people are anticipating that it will be quite expensive. This might also slow
down the market growth through 2025. Furthermore, countries have started working on the generic forms of drug, which might negatively impact the market growth.
The global remdesivir market is segmented based on dosage, route of administration, dosage form, distribution channel, application, company, and region. Based on route of administration, the
market can be bifurcated into oral and intravenous. The intravenous route of administration is expected to dominate the market, since till date, all the patients have been given the drug through this
route only, for treating COVID-19. Based on dosage form, the market can be categorized into tablets, frozen solution, and lypholized solution. The tablets segment is expected to hold a significant
market share since tablets can accumulate a higher dose of active ingredients. Based on application, the market can be fragmented into Ebola, SARS-COV, MERS-COV, and COVID-19. The
COVID-19 segment is expected to dominate the market on account of its effective use in the treatment of this disease. Additionally, the drug has entered the phase 3 clinical trials and is expected to
come out as potent treatment option for the pandemic. The drug has also shown encouraging results in animal model for SARS-COV and MERS-COV.
“North America is expected to dominate the global remdesivir market during forecast period on account of the presence of major players operating in the market. Additionally, Gilead Sciences, which
is the developer of the drug, is also headquartered in California, United States. On the other hand, Asia-Pacific market is also expected to witness significant growth on account of the extensive use
of the drug for the treatment of COVID-19 in countries like China, Japan, among others. Additionally, the Indian Council of Medical Research has recently asked the major market players operating in
the Indian pharmaceutical market to manufacture the drug and Dr. Reddy Laboratories has already started working on its generic form,” said Mr. Karan Chechi, Research Director with TechSci
Research, a research based global management consulting firm.

22. 22
SAMPLE DATA - SNAPSHOT
Global Remdesivir Market Size, By Value (USD Million), 2015-2025F
5.00 6.00 7.00 8.00 9.00 10.00 11.00 12.00 13.00 14.00 15.00
2015 2019 2020E 2025F
By Value (USD Million)
CAGR By Value CAGR By Value
XX% YY%
North America Remdesivir Market Share, By Dosage, By Value, 2015–2025F
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
20%
2015
2016
2017
2018
2019
2020E
2021F
2022F
2023F
2024F
2025F
10 mM*1 mL in DMSO 5mg 10mg 50mg 100mg
United States Remdesivir Market Share, By Application, By Value, 2015–2025F
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
25%
2015
2016
2017
2018
2019
2020E
2021F
2022F
2023F
2024F
2025F
Ebola SARS-COV MERS-COV COVID-19

23. 23
REPORT ORDERING
License Type Price
Electronic Access - Single User License $4450
Electronic Access - Multi-User License $5450
Custom Research License $9450
Report Price
To View Sample OR Purchase Report
Report Name: GLOBAL REMDESIVIR MARKET
FORECAST & OPPORTUNITIES
2015 – 2025

24. About Us & Disclaimer
TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in
number of areas to organizations. The company uses innovative business Modes that focus on improving productivity, while ensuring creation of high-quality
of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’ Mode of a country, regional and global industry
activity and industry trends, the result is a uniquely rich evaluation of the opportunities available in the market.
Related Reports
• Global Self-monitoring Blood Glucose Market By Type (Type 1, Type 2, Hyperglycemia ,Hypoglycemia), By Frequency (One, Four, Others), By
Product (Glucometer, Software, Test Strips, Lancet), By End-User (Hospital, Personal Care), By Region, Forecast & Opportunities, 2025
• Global Infectious Disease Testing Market By Product & Service (Assays, Kits, & Reagents; Instruments; Services & Software), By Technology
(Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Others), By Disease (Hepatitis, HIV, HAIS, HPV, TB, Influenza, Glandular
fever, Coronavirus, Others), By End User (Hospital/Clinical Laboratories, Reference Laboratories, Physician Offices, Academic/Research Institutes,
Other), By Region, Forecast & Opportunities, 2025
The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely,
accurate or complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it
considers reliable and firsthand. However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible
for any errors or omissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the
subscribers / users of this report. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this
document are indicative of relative market size and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior
approval of TechSci Research.
TechSci Research – North America
708 Third Avenue, Manhattan,
New York, United States
Tel: +1- 646- 360- 1656
Email: sales@techsciresearch.com
www.techsciresearch.com
Disclaimer
TechSci Research – Europe
54, Old brook, Bretton,
Peterborough,
United Kingdom
Email: sales@techsciresearch.com
www.techsciresearch.com
TechSci Research – Asia-Pacific
B – 44, Sector – 57, Noida, National Capital
Region, U.P. - India
Tel: +91-120-4523900
Email: sales@techsciresearch.com
www.techsciresearch.com